Cardiac Tamponade Secondary to COVID-19
Mohammed Dabbagh, Lindsey Aurora, Penny D’Souza, Allison Weinmann, Pallavi Bhargava, Mir B. Basir
Abstract
A 67-year-old woman presented with upper respiratory symptoms and was diagnosed with coronavirus disease-2019 (COVID-19). She was found to have a large hemorrhagic pericardial effusion with echocardiographic signs of tamponade and mild left ventricular impairment. Clinical course was complicated by development of takotsubo cardiomyopathy. She was treated with pericardiocentesis, colchicine, corticosteroids, and hydroxychloroquine, with improvement in symptoms. (Level of Difficulty: Intermediate.)
Topics & Concepts
PericardiocentesisMedicinePericardial effusionCardiac tamponadeHydroxychloroquineCardiologyCoronavirus disease 2019 (COVID-19)Internal medicineTamponadeColchicineCardiomyopathyMyocarditisDiseaseHeart failureInfectious disease (medical specialty)Pericarditis and Cardiac TamponadeTakotsubo Cardiomyopathy and Associated PhenomenaCardiac Structural Anomalies and Repair